You are here

  • Home
  • Archive
  • Volume 10, Issue 8
  • Real-world clinical outcomes with avelumab in patients with Merkel cell carcinoma treated in the USA: a multicenter chart review study

Article metrics

Article menu

Download PDFPDF

Clinical/translational cancer immunotherapy
Original research
Real-world clinical outcomes with avelumab in patients with Merkel cell carcinoma treated in the USA: a multicenter chart review study

 

Online download statistics by month:

Online download statistics by month: August 2022 to September 2025

AbstractFullPdf
Aug 2022518522136
Sep 2022278281100
Oct 202233533763
Nov 202217717752
Dec 202213013026
Jan 202312112135
Feb 202311011235
Mar 2023848619
Apr 2023545622
May 2023909124
Jun 202310610651
Jul 2023606136
Aug 2023626226
Sep 2023595923
Oct 2023888928
Nov 2023606021
Dec 2023585822
Jan 2024434422
Feb 2024808027
Mar 2024798183
Apr 2024808038
May 2024616238
Jun 2024838244
Jul 2024788034
Aug 2024515024
Sep 2024555533
Oct 2024666738
Nov 2024596015
Dec 202410110225
Jan 2025575924
Feb 202513613625
Mar 2025808037
Apr 2025676717
May 2025545436
Jun 2025545415
Jul 2025110
Sep 2025210
Total367737031294